Second Affiliated Hospital, School of Medicine, Zhejiang University: Carcinoma, Non-Small-Cell Lung trials

The registry lists 16 Carcinoma, Non-Small-Cell Lung studies with Second Affiliated Hospital, School of Medicine, Zhejiang University as lead sponsor. 7 are open to participants now and 0 have results posted.

Phase 1 4Phase 2 5Phase 3 3No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study of CEA-Targeted CAR-T Therapy in Patients With CEA-Positive Advanced Solid TumorsRecruitingNCT07250386Phase 1
• A Study on Using SFRT With Standard Treatment for Oligoprogressive NSCLCRecruitingNCT07193641Phase 2
• Clinical Study of Combined EphA2-targeted CAR-DC and CAR-T Cell Therapy for Non-small Cell Lung CancerRecruitingNCT06972576Phase 1
• Phase II Clinical Study of Befotertinib in EGFR Non-classical Mutant NSCLCRecruitingNCT06863506Phase 2
• Sleeve Lobectomy for Lung Cancer in Minimally Invasive Surgical TechniquesRecruitingNCT06687408
• Stereotactic Body Radiotherapy for Oligo-Progression Metastatic Non-Small Cell Lung CancerRecruitingNCT06523673Phase 3
• Neoadjuvant Therapy of Sintilimab Combined With Chemotherapy for Resectable Squamous Cell NSCLC（neoSCORE Ⅱ）RecruitingNCT05429463Phase 3
• 18F-FDG PET/CT Radiomics Models for Precision Diagnosis and Prognosis in NSCLCActive, not recruitingNCT07449858
• Serplulimab Combined With Chemotherapy in Patients With Resectable Non-small-cell Lung CancerActive, not recruitingNCT05882513Phase 2
• Application of Pablizumab Combined With Apatinib and Chemotherapy in Resectable Non-small Cell Lung Cancer： A Prospective, Single Arm, Single Center Phase II Clinical Study of Neoadjuvant TherapyStatus unknownNCT04968002Phase 2/3
• Neoadjuvant Immune Checkpoint Inhibitor Combined With Chemotherapy in Non-small Cell Lung CancerStatus unknownNCT04945200
• Neoadjuvant of Sintilimab Combined With Chemotherapy for Resectable NSCLC（neoSCORE）Status unknownNCT04459611Phase 2
• A Study With Pembrolizumab for Non-small Cell Lung Cancer (NSCLC)Status unknownNCT04393883Not applicable
• ICIs Neoadjuvant Therapy in Resectable Non-Small-Cell Lung CancerCompletedNCT03732664Phase 1
• The Treatment of Advanced Lung Cancer With Dribbles Antigen by Targeting Activation of TcellsStatus unknownNCT03057340Phase 1
• Multiple-portal VATS Versus Uniportal VATS Lobectomy for Non-small Cell Lung CancerStatus unknownNCT02462356Not applicable